Arik Ben Ishay
Expand U.S. operations and pursue regulatory approvals by 2026 • Biobeat
"Biobeat CEO Arik Ben Ishay promised to use new capital to expand U.S. operations and pursue broader regulatory approvals for their continuous blood pressure monitoring device by end of 2026."
Made
Jan 6, 2026
Deadline
Dec 31, 2026
Source
Tech Startups ↗
9
Comments (0)
Sign in to join the discussion
No comments yet. Be the first to share your thoughts!